![Douglas Janzen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Janzen
Vorstandsvorsitzender bei
AEQUUS PHARMACEUTICALS INC.
Vermögen: 3 766 $ am 31.10.2026
Profil
Mr. Douglas G.
Janzen is a Managing Director at Northview Ventures & Associates General Partnership, a Managing director&co founder at Northview LifeSciences, a Chairman, President & Chief Executive Officer at Aequus Pharmaceuticals, Inc. and a Chairman at Lexington Biosciences Holdings Corp.
He is on the Board of Directors at Transdermal Research Pharm Laboratories LLC, LifeSciences British Columbia, Alabaster Technologies, Inc. and Synaptive Technologies Ltd. Mr. Janzen was previously employed as a Chairman by Lexington Biosciences, Inc., an Independent Director by iCo Therapeutics, Inc., a President & Chief Business Officer by Bradmer Pharmaceuticals, Inc., an Independent Director by Neovasc, Inc., a President, Chief Executive Officer & Director by Correvio Pharma Corp., a Head of Research by Loewen, Ondaatje, McCutcheon Ltd., a Chairman by AbCellera Biologics, Inc., and an Analyst by Sprott Securities, Inc. He also served on the board at BioHEP Technologies Ltd., AmpHP, Inc., Aptamera, Inc., BIOTECanada, Medical Ventures Corp., Perimeter Medical Imaging AI, Inc., Perimeter Medical Imaging, Inc., Renaissance BioScience Corp., Sentinelle Medical ULC, Synaptive Medical, Inc. and Teal Valley Health, Inc. He received his undergraduate degree from the University of Saskatchewan and a graduate degree from the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.09.2025 | 12.553.800 ( 9,46 % ) | 3 766 $ | 31.10.2026 |
Aktive Positionen von Douglas Janzen
| Unternehmen | Position | Beginn |
|---|---|---|
| AEQUUS PHARMACEUTICALS INC. | Vorstandsvorsitzender | 03.01.2013 |
Northview LifeSciences
 Northview LifeSciences Investment ManagersFinance Northview LifeSciences invests in companies located in Canada. The firm targets companies operating in the fields of health technology and life sciences sectors. It provides financing for growth transactions. | Gründer | 01.04.2014 |
Northview Ventures & Associates General Partnership
 Northview Ventures & Associates General Partnership Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Gründer | 01.04.2014 |
Lexington Biosciences Holdings Corp.
 Lexington Biosciences Holdings Corp. Medical SpecialtiesHealth Technology Operates as a development stage company with interest in medical devices development | Vorsitzender | 23.05.2017 |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Direktor/Vorstandsmitglied | - |
Synaptive Technologies Ltd. | Direktor/Vorstandsmitglied | - |
Transdermal Research Pharm Laboratories LLC
 Transdermal Research Pharm Laboratories LLC Transdermal Research Pharm Laboratories LLC is a contract research laboratory specializing in the research, development, and testing of customized transdermal and topical drug delivery systems. The private company is based in Long Island City, NY. The company serves pharmaceutical, cosmeceutical, nutraceutical, and OTC product sectors, focusing on advancing drug delivery technologies that improve solubility, permeability, bioavailability, and patient compliance through non-invasive, controlled, and sustained release methods. Its services include formulation development, in-vitro and in-vivo testing, analytical and stability studies, regulatory support, safety and efficacy evaluation, quality control, and patent assistance. The company was founded by Fotios Plakogiannis. | Direktor/Vorstandsmitglied | 03.03.2013 |
Alabaster Technologies, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Douglas Janzen
| Unternehmen | Position | Ende |
|---|---|---|
| REGISTERED PLAN PRIVATE INVESTMENTS INC. | Vorsitzender | 01.12.2021 |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Douglas Janzen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
29
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 29 |
|---|---|
Cormark Securities, Inc.
 Cormark Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for commercializing cardiovascular hospital drugs | Health Technology |
Medical Ventures Corp.
 Medical Ventures Corp. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices; researches and develops commercialization of medical equipments | Electronic Technology |
Teal Valley Health, Inc.
 Teal Valley Health, Inc. Packaged SoftwareTechnology Services Develops medical cannabis software platform | Technology Services |
Aptamera, Inc.
 Aptamera, Inc. BiotechnologyHealth Technology Develops drugs designed to attack cancer | Health Technology |
Bradmer Pharmaceuticals, Inc.
 Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies | Commercial Services |
Synaptive Medical, Inc.
 Synaptive Medical, Inc. Medical SpecialtiesHealth Technology Develops medical equipment and applications for neurosurgery | Health Technology |
Aequus Pharmaceuticals, Inc.
 Aequus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of alternatives to currently approved drugs | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Health Technology |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Loewen, Ondaatje, McCutcheon Ltd.
 Loewen, Ondaatje, McCutcheon Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
iCo Therapeutics, Inc.
 iCo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which identifies, develops and commercializes drug candidates to treat ocular and infectious diseases | Health Technology |
Neovasc, Inc.
 Neovasc, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells devices for the treatment of cardiovascular & refractory angina problems | Health Technology |
Sentinelle Medical ULC
 Sentinelle Medical ULC Packaged SoftwareTechnology Services Manufactures software used for MRI's | Technology Services |
BioHEP Technologies Ltd.
 BioHEP Technologies Ltd. BiotechnologyHealth Technology Develops biotechnologies for treatment of viral diseases | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Perimeter Medical Imaging, Inc.
 Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Provides medical services | Health Technology |
Renaissance BioScience Corp.
 Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Develops proprietary technology solutions for food and beverage manufacturers | Commercial Services |
Synaptive Technologies Ltd. | |
Transdermal Research Pharm Laboratories LLC
Transdermal Research Pharm Laboratories LLC Transdermal Research Pharm Laboratories LLC is a contract research laboratory specializing in the research, development, and testing of customized transdermal and topical drug delivery systems. The private company is based in Long Island City, NY. The company serves pharmaceutical, cosmeceutical, nutraceutical, and OTC product sectors, focusing on advancing drug delivery technologies that improve solubility, permeability, bioavailability, and patient compliance through non-invasive, controlled, and sustained release methods. Its services include formulation development, in-vitro and in-vivo testing, analytical and stability studies, regulatory support, safety and efficacy evaluation, quality control, and patent assistance. The company was founded by Fotios Plakogiannis. | |
Northview Ventures & Associates General Partnership
Northview Ventures & Associates General Partnership Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Lexington Biosciences Holdings Corp.
Lexington Biosciences Holdings Corp. Medical SpecialtiesHealth Technology Operates as a development stage company with interest in medical devices development | Health Technology |
Alabaster Technologies, Inc. | |
Lexington Biosciences, Inc.
 Lexington Biosciences, Inc. Medical SpecialtiesHealth Technology Develops cardiovascular health monitors | Health Technology |
AmpHP, Inc.
 AmpHP, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Perimeter Medical Imaging AI, Inc.
 Perimeter Medical Imaging AI, Inc. Medical SpecialtiesHealth Technology Manufactures medical imaging tools | Health Technology |
Northview LifeSciences
Northview LifeSciences Investment ManagersFinance Northview LifeSciences invests in companies located in Canada. The firm targets companies operating in the fields of health technology and life sciences sectors. It provides financing for growth transactions. | Finance |
